It has been thought that the therapeutic effects of abatacept on RA are mediated by suppressing the upstream autoimmune and inflammatory processes by interfering with CD28 binding to CD80/86 on APCs [10, 11]. This evidence concerns the gene CD28 and rheumatoid arthritis.